United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (netherlands) - penfluridol - oral tablet - 20mg

Ireland - English - HPRA (Health Products Regulatory Authority)

janssen pharmaceutica - penfluridol -

Canada - English - Health Canada

boiron laboratoires - clematis erecta - tablet - 2ch - clematis erecta 2ch - homeopathic products

Canada - English - Health Canada

dolisos laboratoires s.a. - clematis erecta - tablet - 1dh - clematis erecta 1dh - homeopathic products

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - lurasidone hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: citric acid; pregelatinised maize starch; magnesium stearate; povidone; lactose monohydrate; mannitol; croscarmellose sodium; titanium dioxide; hypromellose; iron oxide yellow; brilliant blue fcf aluminium lake; macrogol 400 - lurasidone hydrochloride film-coated tablets are indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - lurasidone hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: povidone; lactose monohydrate; mannitol; pregelatinised maize starch; croscarmellose sodium; magnesium stearate; citric acid; titanium dioxide; hypromellose; iron oxide yellow; brilliant blue fcf aluminium lake; macrogol 400 - lurasidone hydrochloride film-coated tablets are indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - lurasidone hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; lactose monohydrate; magnesium stearate; citric acid; pregelatinised maize starch; mannitol; povidone; titanium dioxide; hypromellose; iron oxide yellow; brilliant blue fcf aluminium lake; macrogol 400 - lurasidone hydrochloride film-coated tablets are indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - lurasidone hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: citric acid; croscarmellose sodium; povidone; pregelatinised maize starch; mannitol; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; iron oxide yellow; brilliant blue fcf aluminium lake; macrogol 400 - lurasidone hydrochloride film-coated tablets are indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - lurasidone hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: citric acid; croscarmellose sodium; lactose monohydrate; povidone; magnesium stearate; pregelatinised maize starch; titanium dioxide; hypromellose; macrogol 400 - lurasidone hydrochloride film-coated tablets are indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - lurasidone hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: citric acid; lactose monohydrate; magnesium stearate; povidone; croscarmellose sodium; mannitol; pregelatinised maize starch; titanium dioxide; hypromellose; macrogol 400 - lurasidone hydrochloride film-coated tablets are indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).